Genentech
Genentech’s retiring R&D head to be replaced by MIT executive
May 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment
Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
Roche signs deal with Skyhawk over molecules that modulate RNA splicing
July 17, 2019Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing
Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
Genentech signs $1 billion deal with Sosei over GCPRs
July 17, 2019Research and Development Genentech, Roche, gcprs, pharma, sosei
Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …
FDA greenlights Pfizer biosimilar version of Genentech’s Avastin
July 1, 2019Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology
Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …
Ocrevus becomes first NICE-approved therapy on the NHS for primary progressive multiple sclerosis
May 9, 2019Sales and Marketing Genentech, NHS, NICE, Ocrevus, UK
NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the …
Top Ten most popular articles on Pharmafile.com this week!
April 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma
This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
Genentech employee awarded $250,000 over racial discrimination case
April 16, 2019Manufacturing and Production Genentech, discrimination, pharma, racial discrimination, racism
A US jury has awarded a former Genentech employee nearly $250,000 after the black worker was fired from the firm …
23andMe to offer genetic reports on diabetes
March 11, 2019Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics
Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …
Alexander Hardy returns to Genentech as new CEO
February 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Alexander Hardy returns to Genentech as new CEO
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma
Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
Roche’s Genentech inks potential $2bn personalised cancer drug development deal
January 7, 2019Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma
Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …
FDA approves first Rituxan biosimilar courtesy of Teva and Celltrion
November 29, 2018Sales and Marketing FDA, Genentech, Rituxan, Roche, Teva, Truxima, biosimilars, celltrion
The FDA has announced the first US approval of a biosimilar version of Genentech’s Rituxan (rituximab), awarding marketing approval to …
Roche’s Genentech to acquire inflammatory drug discovery firm Jecure
November 28, 2018Research and Development, Sales and Marketing Genentech, Jecure, Roche, liver disease, nash, pharma
Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of …
Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration
October 29, 2018Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma
Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …
Genentech to axe 223 staff from San Francisco HQ
August 17, 2018Manufacturing and Production, Medical Communications Genentech, Roche, layoffs, pharma
Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 …
Latest content
Five Facts about cardiovascular disease
